Selected research
Market Structure
Global Fibrin Sealants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fibrin Sealants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fibrin Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fibrin Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fibrin Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fibrin Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fibrin Sealants include Asahi Kasei Medical, C.R. Bard, CSL Behring, Harvest Technologies, Hualan Biological, KM Biologics, LifeBond, Pharming Group and Sea Run, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fibrin Sealants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fibrin Sealants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fibrin Sealants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fibrin Sealants market size, projected growth trends, production technologies, key applications, and end-use industries.
Fibrin Sealants Segment by Company
Asahi Kasei Medical
C.R. Bard
CSL Behring
Harvest Technologies
Hualan Biological
KM Biologics
LifeBond
Pharming Group
Sea Run
STB Lifesaving Technologies
Tissuemed
Z-Medica
Baxter International
Johnson & Johnson (Ethicon)
Shanghai RAAS
Fibrin Sealants Segment by Type
2mL/Set
4mL/Set
10mL/Set
Fibrin Sealants Segment by Application
Hospitals
Clinics
Other
Fibrin Sealants Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Sealants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Sealants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Sealants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fibrin Sealants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibrin Sealants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibrin Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fibrin Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2mL/Set
- 4mL/Set
- 10mL/Set
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Asahi Kasei Medical
- C.R. Bard
- CSL Behring
- Harvest Technologies
- Hualan Biological
- KM Biologics
- LifeBond
- Pharming Group
- Sea Run
- STB Lifesaving Technologies
- Tissuemed
- Z-Medica
- Baxter International
- Johnson & Johnson (Ethicon)
- Shanghai RAAS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fibrin Sealants Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fibrin Sealants Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fibrin Sealants Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fibrin Sealants Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fibrin Sealants Market Dynamics
- 2.1 Fibrin Sealants Industry Trends
- 2.2 Fibrin Sealants Industry Drivers
- 2.3 Fibrin Sealants Industry Opportunities and Challenges
- 2.4 Fibrin Sealants Industry Restraints
3 Fibrin Sealants Market by Manufacturers
- 3.1 Global Fibrin Sealants Revenue by Manufacturers (2021-2026)
- 3.2 Global Fibrin Sealants Sales by Manufacturers (2021-2026)
- 3.3 Global Fibrin Sealants Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fibrin Sealants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fibrin Sealants Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fibrin Sealants Manufacturers, Product Type & Application
- 3.7 Global Fibrin Sealants Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fibrin Sealants Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fibrin Sealants Players Market Share by Revenue in 2025
- 3.8.3 2025 Fibrin Sealants Tier 1, Tier 2, and Tier 3
4 Fibrin Sealants Market by Type
- 4.1 Fibrin Sealants Type Introduction
- 4.1.1 2mL/Set
- 4.1.2 4mL/Set
- 4.1.3 10mL/Set
- 4.2 Global Fibrin Sealants Sales by Type
- 4.2.1 Global Fibrin Sealants Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fibrin Sealants Sales by Type (2021-2032)
- 4.2.3 Global Fibrin Sealants Sales Market Share by Type (2021-2032)
- 4.3 Global Fibrin Sealants Revenue by Type
- 4.3.1 Global Fibrin Sealants Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fibrin Sealants Revenue by Type (2021-2032)
- 4.3.3 Global Fibrin Sealants Revenue Market Share by Type (2021-2032)
5 Fibrin Sealants Market by Application
- 5.1 Fibrin Sealants Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Fibrin Sealants Sales by Application
- 5.2.1 Global Fibrin Sealants Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fibrin Sealants Sales by Application (2021-2032)
- 5.2.3 Global Fibrin Sealants Sales Market Share by Application (2021-2032)
- 5.3 Global Fibrin Sealants Revenue by Application
- 5.3.1 Global Fibrin Sealants Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fibrin Sealants Revenue by Application (2021-2032)
- 5.3.3 Global Fibrin Sealants Revenue Market Share by Application (2021-2032)
6 Global Fibrin Sealants Sales by Region
- 6.1 Global Fibrin Sealants Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fibrin Sealants Sales by Region (2021-2032)
- 6.2.1 Global Fibrin Sealants Sales by Region (2021-2026)
- 6.2.2 Global Fibrin Sealants Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fibrin Sealants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fibrin Sealants Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fibrin Sealants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fibrin Sealants Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fibrin Sealants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fibrin Sealants Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fibrin Sealants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fibrin Sealants Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fibrin Sealants Revenue by Region
- 7.1 Global Fibrin Sealants Revenue by Region
- 7.1.1 Global Fibrin Sealants Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fibrin Sealants Revenue by Region (2021-2026)
- 7.1.3 Global Fibrin Sealants Revenue by Region (2027-2032)
- 7.1.4 Global Fibrin Sealants Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fibrin Sealants Revenue (2021-2032)
- 7.2.2 North America Fibrin Sealants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fibrin Sealants Revenue (2021-2032)
- 7.3.2 Europe Fibrin Sealants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fibrin Sealants Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fibrin Sealants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fibrin Sealants Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fibrin Sealants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Asahi Kasei Medical
- 8.1.1 Asahi Kasei Medical Company Information
- 8.1.2 Asahi Kasei Medical Business Overview
- 8.1.3 Asahi Kasei Medical Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Asahi Kasei Medical Fibrin Sealants Product Portfolio
- 8.1.5 Asahi Kasei Medical Recent Developments
- 8.2 C.R. Bard
- 8.2.1 C.R. Bard Company Information
- 8.2.2 C.R. Bard Business Overview
- 8.2.3 C.R. Bard Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 C.R. Bard Fibrin Sealants Product Portfolio
- 8.2.5 C.R. Bard Recent Developments
- 8.3 CSL Behring
- 8.3.1 CSL Behring Company Information
- 8.3.2 CSL Behring Business Overview
- 8.3.3 CSL Behring Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CSL Behring Fibrin Sealants Product Portfolio
- 8.3.5 CSL Behring Recent Developments
- 8.4 Harvest Technologies
- 8.4.1 Harvest Technologies Company Information
- 8.4.2 Harvest Technologies Business Overview
- 8.4.3 Harvest Technologies Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Harvest Technologies Fibrin Sealants Product Portfolio
- 8.4.5 Harvest Technologies Recent Developments
- 8.5 Hualan Biological
- 8.5.1 Hualan Biological Company Information
- 8.5.2 Hualan Biological Business Overview
- 8.5.3 Hualan Biological Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hualan Biological Fibrin Sealants Product Portfolio
- 8.5.5 Hualan Biological Recent Developments
- 8.6 KM Biologics
- 8.6.1 KM Biologics Company Information
- 8.6.2 KM Biologics Business Overview
- 8.6.3 KM Biologics Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 KM Biologics Fibrin Sealants Product Portfolio
- 8.6.5 KM Biologics Recent Developments
- 8.7 LifeBond
- 8.7.1 LifeBond Company Information
- 8.7.2 LifeBond Business Overview
- 8.7.3 LifeBond Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 LifeBond Fibrin Sealants Product Portfolio
- 8.7.5 LifeBond Recent Developments
- 8.8 Pharming Group
- 8.8.1 Pharming Group Company Information
- 8.8.2 Pharming Group Business Overview
- 8.8.3 Pharming Group Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pharming Group Fibrin Sealants Product Portfolio
- 8.8.5 Pharming Group Recent Developments
- 8.9 Sea Run
- 8.9.1 Sea Run Company Information
- 8.9.2 Sea Run Business Overview
- 8.9.3 Sea Run Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sea Run Fibrin Sealants Product Portfolio
- 8.9.5 Sea Run Recent Developments
- 8.10 STB Lifesaving Technologies
- 8.10.1 STB Lifesaving Technologies Company Information
- 8.10.2 STB Lifesaving Technologies Business Overview
- 8.10.3 STB Lifesaving Technologies Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 STB Lifesaving Technologies Fibrin Sealants Product Portfolio
- 8.10.5 STB Lifesaving Technologies Recent Developments
- 8.11 Tissuemed
- 8.11.1 Tissuemed Company Information
- 8.11.2 Tissuemed Business Overview
- 8.11.3 Tissuemed Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Tissuemed Fibrin Sealants Product Portfolio
- 8.11.5 Tissuemed Recent Developments
- 8.12 Z-Medica
- 8.12.1 Z-Medica Company Information
- 8.12.2 Z-Medica Business Overview
- 8.12.3 Z-Medica Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Z-Medica Fibrin Sealants Product Portfolio
- 8.12.5 Z-Medica Recent Developments
- 8.13 Baxter International
- 8.13.1 Baxter International Company Information
- 8.13.2 Baxter International Business Overview
- 8.13.3 Baxter International Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Baxter International Fibrin Sealants Product Portfolio
- 8.13.5 Baxter International Recent Developments
- 8.14 Johnson & Johnson (Ethicon)
- 8.14.1 Johnson & Johnson (Ethicon) Company Information
- 8.14.2 Johnson & Johnson (Ethicon) Business Overview
- 8.14.3 Johnson & Johnson (Ethicon) Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Johnson & Johnson (Ethicon) Fibrin Sealants Product Portfolio
- 8.14.5 Johnson & Johnson (Ethicon) Recent Developments
- 8.15 Shanghai RAAS
- 8.15.1 Shanghai RAAS Company Information
- 8.15.2 Shanghai RAAS Business Overview
- 8.15.3 Shanghai RAAS Fibrin Sealants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Shanghai RAAS Fibrin Sealants Product Portfolio
- 8.15.5 Shanghai RAAS Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fibrin Sealants Value Chain Analysis
- 9.1.1 Fibrin Sealants Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fibrin Sealants Production Mode & Process
- 9.2 Fibrin Sealants Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fibrin Sealants Distributors
- 9.2.3 Fibrin Sealants Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst